Skip to main content
Top
Published in: Acta Neurochirurgica 9/2009

01-09-2009 | Clinical Article

Detection of tumour invasion into the pyramidal tract in glioma patients with sensorimotor deficits by correlation of 18F-fluoroethyl-L-tyrosine PET and magnetic resonance diffusion tensor imaging

Authors: Andreas Stadlbauer, Esther Pölking, Olaf Prante, Christopher Nimsky, Michael Buchfelder, Torsten Kuwert, Rainer Linke, Marc Doelken, Oliver Ganslandt

Published in: Acta Neurochirurgica | Issue 9/2009

Login to get access

Abstract

Purpose

Standard magnetic resonance imaging (MRI) does not depict the true extent of tumour cell invasion in gliomas. We investigated the feasibility of advanced imaging methods, i.e. diffusion tensor imaging (DTI), fibre tracking and O-(2-[18F]-fluoroethyl)-L-tyrosine (18F-FET) PET, for the detection of tumour invasion into white matter structures not visible in routine MRI.

Methods

DTI and fibre tracking was performed on ten patients with gliomas, WHO grades II-IV. Five patients experienced preoperative sensorimotor deficits. The ratio of fractional anisotropy (FA) between the ipsilateral and contralateral pyramidal tract was calculated. Twenty-one stereotactic biopsies from five patients were histopathologically evaluated for the absolute numbers and percentages of tumour cells. 18F-FET PET scans were performed and the bilateral ratio [ipsilateral-to-contralateral ratio (ICR)] of 18F-FET-uptake was calculated for both cross-sections of pyramidal tracts and biopsy sites.

Results

The FA ratio within the pyramidal tract was lower in patients with sensorimotor deficits (0.61–1.06) compared with the FA ratio in patients without sensorimotor deficits (0.92–1.06). In patients with preoperative sensorimotor deficits, we found a significantly (p = 0.028) higher ICR of 18F-FET uptake (1.01–1.59) than in patients without any deficits (0.96–1.08). The ICR of 18F-FET-uptake showed a strong correlation (r = 0.696, p = 0.001) with the absolute number of tumour cells and a moderate correlation (r = 0.535, p = 0.012) with the percentage of tumour cells.

Conclusions

Our data show an association between preoperative sensorimotor deficits, increased 18F-FET uptake and decreased FA ratio in the pyramidal tract. We demonstrated a correlation between tumour invasion and 18F-FET uptake. These findings may help to distinguish between edema versus tumour-associated neurological deficits and could prevent the destruction of important structures, like the pyramidal tract, during tumour operations by allowing more precise preoperative planning.
Literature
1.
go back to reference Berman JI, Berger MS, Chung SW, Nagarajan SS, Henry RG (2007) Accuracy of diffusion tensor magnetic resonance imaging tractography assessed using intraoperative subcortical stimulation mapping and magnetic source imaging. J Neurosurg 107:488–494. doi:10.3171/JNS-07/09/0488 PubMedCrossRef Berman JI, Berger MS, Chung SW, Nagarajan SS, Henry RG (2007) Accuracy of diffusion tensor magnetic resonance imaging tractography assessed using intraoperative subcortical stimulation mapping and magnetic source imaging. J Neurosurg 107:488–494. doi:10.​3171/​JNS-07/​09/​0488 PubMedCrossRef
2.
go back to reference Berman JI, Berger MS, Mukherjee P, Henry RG (2004) Diffusion-tensor imaging-guided tracking of fibers of the pyramidal tract combined with intraoperative cortical stimulation mapping in patients with gliomas. J Neurosurg 101:66–72PubMedCrossRef Berman JI, Berger MS, Mukherjee P, Henry RG (2004) Diffusion-tensor imaging-guided tracking of fibers of the pyramidal tract combined with intraoperative cortical stimulation mapping in patients with gliomas. J Neurosurg 101:66–72PubMedCrossRef
6.
go back to reference Deichen JT, Prante O, Gack M, Schmiedehausen K, Kuwert T (2003) Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 30:267–273PubMed Deichen JT, Prante O, Gack M, Schmiedehausen K, Kuwert T (2003) Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 30:267–273PubMed
7.
go back to reference Floeth FW, Pauleit D, Sabel M, Reifenberger G, Stoffels G, Stummer W, Rommel F, Hamacher K, Langen KJ (2006) 18F-FET PET differentiation of ring-enhancing brain lesions. J Nucl Med 47:776–782PubMed Floeth FW, Pauleit D, Sabel M, Reifenberger G, Stoffels G, Stummer W, Rommel F, Hamacher K, Langen KJ (2006) 18F-FET PET differentiation of ring-enhancing brain lesions. J Nucl Med 47:776–782PubMed
8.
go back to reference Floeth FW, Pauleit D, Sabel M, Stoffels G, Reifenberger G, Riemenschneider MJ, Jansen P, Coenen HH, Steiger HJ, Langen KJ (2007) Prognostic value of O-(2-[18F]-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma. J Nucl Med 48:519–527. doi:10.2967/jnumed.106.037895 PubMedCrossRef Floeth FW, Pauleit D, Sabel M, Stoffels G, Reifenberger G, Riemenschneider MJ, Jansen P, Coenen HH, Steiger HJ, Langen KJ (2007) Prognostic value of O-(2-[18F]-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma. J Nucl Med 48:519–527. doi:10.​2967/​jnumed.​106.​037895 PubMedCrossRef
9.
10.
go back to reference Gruber S, Mlynarik V, Moser E (2003) High-resolution 3D proton spectroscopic imaging of the human brain at 3 T: SNR issues and application for anatomy-matched voxel sizes. Magn Reson Med 49:299–306. doi:10.1002/mrm.10377 PubMedCrossRef Gruber S, Mlynarik V, Moser E (2003) High-resolution 3D proton spectroscopic imaging of the human brain at 3 T: SNR issues and application for anatomy-matched voxel sizes. Magn Reson Med 49:299–306. doi:10.​1002/​mrm.​10377 PubMedCrossRef
11.
go back to reference Herzog H, Tellmann L, Hocke C, Pietrzyk U, Casey ME, Kuwert T (2004) NEMA NU2–2001 guided performance evaluation of four Siemens ECAT PET-Scanners. IEEE Trans Nucl Sci 51:2662–2669. doi:10.1109/TNS.2004.835778 CrossRef Herzog H, Tellmann L, Hocke C, Pietrzyk U, Casey ME, Kuwert T (2004) NEMA NU2–2001 guided performance evaluation of four Siemens ECAT PET-Scanners. IEEE Trans Nucl Sci 51:2662–2669. doi:10.​1109/​TNS.​2004.​835778 CrossRef
15.
go back to reference Kaim AH, Weber B, Kurrer MO, Westera G, Schweitzer A, Gottschalk J, von Schulthess GK, Buck A (2002) 18F-FDG and 18F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 29:648–654. doi:10.1007/s00259-002-0780-y PubMedCrossRef Kaim AH, Weber B, Kurrer MO, Westera G, Schweitzer A, Gottschalk J, von Schulthess GK, Buck A (2002) 18F-FDG and 18F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 29:648–654. doi:10.​1007/​s00259-002-0780-y PubMedCrossRef
16.
go back to reference Kamada K, Todo T, Masutani Y, Aoki S, Ino K, Takano T, Kirino T, Kawahara N, Morita A (2005) Combined use of tractography-integrated functional neuronavigation and direct fiber stimulation. J Neurosurg 102:664–672PubMedCrossRef Kamada K, Todo T, Masutani Y, Aoki S, Ino K, Takano T, Kirino T, Kawahara N, Morita A (2005) Combined use of tractography-integrated functional neuronavigation and direct fiber stimulation. J Neurosurg 102:664–672PubMedCrossRef
17.
go back to reference Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533–536PubMedCrossRef Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533–536PubMedCrossRef
18.
go back to reference Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972–1980PubMed Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972–1980PubMed
19.
21.
go back to reference Mori S, Kaufmann WE, Davatzikos C, Stieltjes B, Amodei L, Fredericksen K, Pearlson GD, Melhem ER, Solaiyappan M, Raymond GV, Moser HW, van Zijl PC (2002) Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med 47:215–223. doi:10.1002/mrm.10074 PubMedCrossRef Mori S, Kaufmann WE, Davatzikos C, Stieltjes B, Amodei L, Fredericksen K, Pearlson GD, Melhem ER, Solaiyappan M, Raymond GV, Moser HW, van Zijl PC (2002) Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med 47:215–223. doi:10.​1002/​mrm.​10074 PubMedCrossRef
23.
go back to reference Nimsky C, Ganslandt O, Hastreiter P, Wang R, Benner T, Sorensen AG, Fahlbusch R (2005) Intraoperative diffusion-tensor MR imaging: shifting of white matter tracts during neurosurgical procedures–initial experience. Radiology 234:218–225. doi:10.1148/radiol.2341031984 PubMedCrossRef Nimsky C, Ganslandt O, Hastreiter P, Wang R, Benner T, Sorensen AG, Fahlbusch R (2005) Intraoperative diffusion-tensor MR imaging: shifting of white matter tracts during neurosurgical procedures–initial experience. Radiology 234:218–225. doi:10.​1148/​radiol.​2341031984 PubMedCrossRef
24.
go back to reference Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann L, Herzog H, Broer S, Coenen HH, Langen KJ (2005) PET with O-(2-[18F]fluoroethyl)-L-tyrosine in peripheral tumors: First clinical results. J Nucl Med 46:411–416PubMed Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann L, Herzog H, Broer S, Coenen HH, Langen KJ (2005) PET with O-(2-[18F]fluoroethyl)-L-tyrosine in peripheral tumors: First clinical results. J Nucl Med 46:411–416PubMed
26.
go back to reference Pöpperl G, Goldbrunner R, Gildehaus FJ, Kreth FW, Tanner P, Holtmannspotter M, Tonn JC, Tatsch K (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging 32:1018–1025. doi:10.1007/s00259-005-1819-7 PubMedCrossRef Pöpperl G, Goldbrunner R, Gildehaus FJ, Kreth FW, Tanner P, Holtmannspotter M, Tonn JC, Tatsch K (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging 32:1018–1025. doi:10.​1007/​s00259-005-1819-7 PubMedCrossRef
27.
28.
go back to reference Pöpperl G, Kreth FW, Herms J, Koch W, Mehrkens JH, Gildehaus FJ, Kretzschmar HA, Tonn JC, Tatsch K (2006) Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med 47:393–403PubMed Pöpperl G, Kreth FW, Herms J, Koch W, Mehrkens JH, Gildehaus FJ, Kretzschmar HA, Tonn JC, Tatsch K (2006) Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med 47:393–403PubMed
30.
go back to reference Rachinger W, Goetz C, Pöpperl G, Gildehaus FJ, Kreth FW, Holtmannspotter M, Herms J, Koch W, Tatsch K, Tonn JC (2005) Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 57:505–511. doi:10.1227/01.NEU.0000171642.49553.B0 PubMedCrossRef Rachinger W, Goetz C, Pöpperl G, Gildehaus FJ, Kreth FW, Holtmannspotter M, Herms J, Koch W, Tatsch K, Tonn JC (2005) Positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 57:505–511. doi:10.​1227/​01.​NEU.​0000171642.​49553.​B0 PubMedCrossRef
31.
go back to reference Rau FC, Weber WA, Wester HJ, Herz M, Becker I, Kruger A, Schwaiger M, Senekowitsch-Schmidtke R (2002) O-(2-[18F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 29:1039–1046. doi:10.1007/s00259-002-0821-6 PubMedCrossRef Rau FC, Weber WA, Wester HJ, Herz M, Becker I, Kruger A, Schwaiger M, Senekowitsch-Schmidtke R (2002) O-(2-[18F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 29:1039–1046. doi:10.​1007/​s00259-002-0821-6 PubMedCrossRef
32.
go back to reference Roberts TP, Liu F, Kassner A, Mori S, Guha A (2005) Fiber density index correlates with reduced fractional anisotropy in white matter of patients with glioblastoma. AJNR Am J Neuroradiol 26:2183–2186PubMed Roberts TP, Liu F, Kassner A, Mori S, Guha A (2005) Fiber density index correlates with reduced fractional anisotropy in white matter of patients with glioblastoma. AJNR Am J Neuroradiol 26:2183–2186PubMed
33.
go back to reference Schonberg T, Pianka P, Hendler T, Pasternak O, Assaf Y (2006) Characterization of displaced white matter by brain tumors using combined DTI and fMRI. Neuroimage Schonberg T, Pianka P, Hendler T, Pasternak O, Assaf Y (2006) Characterization of displaced white matter by brain tumors using combined DTI and fMRI. Neuroimage
34.
go back to reference Stadlbauer A, Ganslandt O, Buslei R, Hammen T, Gruber S, Moser E, Buchfelder M, Salomonowitz E, Nimsky C (2006) Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 240:803–810. doi:10.1148/radiol.2403050937 PubMedCrossRef Stadlbauer A, Ganslandt O, Buslei R, Hammen T, Gruber S, Moser E, Buchfelder M, Salomonowitz E, Nimsky C (2006) Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 240:803–810. doi:10.​1148/​radiol.​2403050937 PubMedCrossRef
35.
go back to reference Stadlbauer A, Nimsky C, Buslei R, Salomonowitz E, Hammen T, Buchfelder M, Moser E, Ernst-Stecken A, Ganslandt O (2007) Diffusion tensor imaging and optimized fiber tracking in glioma patients: Histopathologic evaluation of tumor-invaded white matter structures. Neuroimage 34:949–956. doi:10.1016/j.neuroimage.2006.08.051 PubMedCrossRef Stadlbauer A, Nimsky C, Buslei R, Salomonowitz E, Hammen T, Buchfelder M, Moser E, Ernst-Stecken A, Ganslandt O (2007) Diffusion tensor imaging and optimized fiber tracking in glioma patients: Histopathologic evaluation of tumor-invaded white matter structures. Neuroimage 34:949–956. doi:10.​1016/​j.​neuroimage.​2006.​08.​051 PubMedCrossRef
36.
go back to reference Stadlbauer A, Nimsky C, Gruber S, Moser E, Hammen T, Engelhorn T, Buchfelder M, Ganslandt O (2007) Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. AJNR Am J Neuroradiol 28:462–469PubMed Stadlbauer A, Nimsky C, Gruber S, Moser E, Hammen T, Engelhorn T, Buchfelder M, Ganslandt O (2007) Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. AJNR Am J Neuroradiol 28:462–469PubMed
37.
go back to reference Stadlbauer A, Prante O, Nimsky C, Salomonowitz E, Buchfelder M, Kuwert T, Linke R, Ganslandt O (2008) Metabolic imaging of cerebral gliomas: spatial correlation of changes in O-(2–18F-fluoroethyl)-L-tyrosine PET and proton magnetic resonance spectroscopic imaging. J Nucl Med 49:721–729. doi:10.2967/jnumed.107.049213 PubMedCrossRef Stadlbauer A, Prante O, Nimsky C, Salomonowitz E, Buchfelder M, Kuwert T, Linke R, Ganslandt O (2008) Metabolic imaging of cerebral gliomas: spatial correlation of changes in O-(2–18F-fluoroethyl)-L-tyrosine PET and proton magnetic resonance spectroscopic imaging. J Nucl Med 49:721–729. doi:10.​2967/​jnumed.​107.​049213 PubMedCrossRef
38.
go back to reference Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, Kurlemann G, Wassmann H, Coenen HH, Schober O (2005) O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging 32:422–429. doi:10.1007/s00259-004-1705-8 PubMedCrossRef Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, Kurlemann G, Wassmann H, Coenen HH, Schober O (2005) O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging 32:422–429. doi:10.​1007/​s00259-004-1705-8 PubMedCrossRef
39.
go back to reference Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, Stocklin G (1999) Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 40:205–212PubMed Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, Stocklin G (1999) Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 40:205–212PubMed
40.
go back to reference Yamada K, Kizu O, Mori S, Ito H, Nakamura H, Yuen S, Kubota T, Tanaka O, Akada W, Sasajima H, Mineura K, Nishimura T (2003) Brain fiber tracking with clinically feasible diffusion-tensor MR imaging: initial experience. Radiology 227:295–301. doi:10.1148/radiol.2271020313 PubMedCrossRef Yamada K, Kizu O, Mori S, Ito H, Nakamura H, Yuen S, Kubota T, Tanaka O, Akada W, Sasajima H, Mineura K, Nishimura T (2003) Brain fiber tracking with clinically feasible diffusion-tensor MR imaging: initial experience. Radiology 227:295–301. doi:10.​1148/​radiol.​2271020313 PubMedCrossRef
Metadata
Title
Detection of tumour invasion into the pyramidal tract in glioma patients with sensorimotor deficits by correlation of 18F-fluoroethyl-L-tyrosine PET and magnetic resonance diffusion tensor imaging
Authors
Andreas Stadlbauer
Esther Pölking
Olaf Prante
Christopher Nimsky
Michael Buchfelder
Torsten Kuwert
Rainer Linke
Marc Doelken
Oliver Ganslandt
Publication date
01-09-2009
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 9/2009
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-009-0378-2

Other articles of this Issue 9/2009

Acta Neurochirurgica 9/2009 Go to the issue